Registered entities
Innovation
171 patent families (80 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Emerging technologies; filing pace steady. Cited 32,188 times.
| Year | Filings |
|---|---|
| 2015 | 23 |
| 2016 | 26 |
| 2017 | 26 |
| 2018 | 22 |
| 2019 | 17 |
| 2020 | 16 |
| 2021 | 23 |
| 2022 | 15 |
| 2023 | 18 |
| 2024 | 17 |
| 2025 | 24 |
| 2026 | 8 |
Social engagement
Social engagement: 27K social following, 10 posts in the last 12 months — above the industry median.
Investor mix
16 investors on record; lead investors include Fidelity Investments, Invesco; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 56% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 6 | 38% |
Hiring activity
Hires periodically
15 roles tracked across 4 of the last 12 months
14 Feb 2026 · CMC Analytical Chemistry Lead for Next-Gen Neuro Drugs · Toronto
13 Feb 2026 · Associate Director, Quality Assurance, GMP · Burnaby
13 Feb 2026 · Associate Director, GMP QA — Lead Compliance & Inspections · Burnaby
21 Jan 2026 · Director/Senior Director, Bioanalytical · Toronto
21 Dec 2025 · Senior QA Director, GMP & Compliance · Burnaby
Based on job postings tracked across public sources.